Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2024

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.
EventHumanPharmacovigilance

Greek is available via eTranslation, the European Commission's machine translation service.

Translate to Greek | Important information about machine translation

Date

Δευτέρα, 5 Φεβρουάριος 2024, Ολοήμερο
Πέμπτη, 8 Φεβρουάριος 2024, Ολοήμερο

Τοποθεσία

European Medicines Agency, Amsterdam, the Netherlands

Documents

Agenda of the PRAC meeting 5-8 February 2024

Draft Reference Number: EMA/PRAC/11237/2024 Corr.1

English (EN) (529.37 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά: Τελευταία ενημέρωση:
Προβολή

Minutes of the PRAC meeting 5-8 February 2024

Adopted Reference Number: EMA/PRAC/122241/2024

English (EN) (875.86 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά:
Προβολή

Share this page